Pegylated interferon alpha-2a for essential thrombocythemia during pregnancy: outcome and safety. A case series

Haematologica. 2016 May;101(5):e182-4. doi: 10.3324/haematol.2015.139691. Epub 2016 Jan 27.

¹ Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London.
² Department of Haematology, St James's University Hospital, Leeds, UK.
³ Institute of Cancer & Genetics, School of Medicine, Cardiff University, UK.
⁴ Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
⁵ Department of Haematology, Countess of Chester Hospital, UK.
⁶ Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London [email protected].

No abstract available

Keywords: essential thrombocythemia; outcomes; pegylated interferon; pregnancy; safety.

Publication types